Keywords: biogen, announces, fda, review, meeting, announced, april
Biogen announces FDA review meeting
Article | 08 April 2002
Biogen announced on April 1, 2002, that the US Food and DrugAdministration will convene a Dermatologic and Ophthalmic Drugs Advisory Committee on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
